Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

July 2014 - FRMC

07/22/2014

Tim Casey

Tim Casey
Chicago—Patients with advanced, progressive non-small cell lung cancer (NSCLC) who received ramucirumab plus docetaxel had a significant improvement in overall survival and progression-free survival compared with a group taking docetaxel and...
Chicago—Patients with advanced, progressive non-small cell lung cancer (NSCLC) who received ramucirumab plus docetaxel had a significant improvement in overall survival and progression-free survival compared with a group taking docetaxel and...
Chicago—Patients with advanced,...
07/22/2014
First Report Managed Care
07/22/2014

Mary Mihalovic

Mary Mihalovic
Among patients with myopic choroidal neovascularization (CNV), the use of either of the 2 antivascular endothelial growth factor (VEGF) agents, ranibizumab or bevacizumab, led to functional and anatomical visual improvement, according to...
Among patients with myopic choroidal neovascularization (CNV), the use of either of the 2 antivascular endothelial growth factor (VEGF) agents, ranibizumab or bevacizumab, led to functional and anatomical visual improvement, according to...
Among patients with myopic...
07/22/2014
First Report Managed Care
07/22/2014

Mary Mihaolvic

Mary Mihaolvic
Patients with neovascular age-related macular degeneration (nAMD) experienced improvement in visual acuity on an observe-and-plan regimen with the antivascular endothelial growth factor agent, ranibizumab, which also reduced clinical burden...
Patients with neovascular age-related macular degeneration (nAMD) experienced improvement in visual acuity on an observe-and-plan regimen with the antivascular endothelial growth factor agent, ranibizumab, which also reduced clinical burden...
Patients with neovascular...
07/22/2014
First Report Managed Care
07/22/2014

Sarah O'Brien

Sarah O'Brien
In 2004, the United States Preventive Services Task Force (USPSTF) recommended against screening asymptomatic people for hepatitis B virus (HBV) infection on the basis of lack of evidence that screening would improve clinical outcomes,...
In 2004, the United States Preventive Services Task Force (USPSTF) recommended against screening asymptomatic people for hepatitis B virus (HBV) infection on the basis of lack of evidence that screening would improve clinical outcomes,...
In 2004, the United States...
07/22/2014
First Report Managed Care
07/22/2014

Mary Beth Nierengarten

Mary Beth Nierengarten
Results of a pharmacoeconomic analysis showed that single-agent bendamustine is a cost-effective treatment option as first-line treatment for patients with Binet stage B or C chronic lymphocytic leukemia (CLL) compared to alemtuzumab and...
Results of a pharmacoeconomic analysis showed that single-agent bendamustine is a cost-effective treatment option as first-line treatment for patients with Binet stage B or C chronic lymphocytic leukemia (CLL) compared to alemtuzumab and...
Results of a pharmacoeconomic...
07/22/2014
First Report Managed Care
07/22/2014

Mary Beth Nierengarten

Mary Beth Nierengarten
Results of a large, multicenter, double-blind, randomized, placebo-controlled trial found that patients with sepsis-associated acute respiratory distress syndrome (ARDS) treated with rosuvastatin had no reduction in in-hospital mortality or...
Results of a large, multicenter, double-blind, randomized, placebo-controlled trial found that patients with sepsis-associated acute respiratory distress syndrome (ARDS) treated with rosuvastatin had no reduction in in-hospital mortality or...
Results of a large, multicenter,...
07/22/2014
First Report Managed Care
07/22/2014

Sarah O'Brien

Sarah O'Brien
In the United States, heart failure is a leading cause of hospitalization, as 25% of patients hospitalized for heart failure are readmitted within 30 days. A recent systematic review was conducted for the Effective Health Care Program of the...
In the United States, heart failure is a leading cause of hospitalization, as 25% of patients hospitalized for heart failure are readmitted within 30 days. A recent systematic review was conducted for the Effective Health Care Program of the...
In the United States, heart...
07/22/2014
First Report Managed Care
07/22/2014
First Report Managed Care conducted an interview with Barney S. Spivack, MD, FACP, one of our Editorial Advisory Board members, to discuss how the aging population will affect Medicare coverage and spending now and in the future. Here you...
First Report Managed Care conducted an interview with Barney S. Spivack, MD, FACP, one of our Editorial Advisory Board members, to discuss how the aging population will affect Medicare coverage and spending now and in the future. Here you...
First Report Managed Care...
07/22/2014
First Report Managed Care
07/22/2014

Kerri Fitzgerald

Kerri Fitzgerald
Four years after the Patient Protection and Affordable Care Act (ACA) was passed and just months into the first year of healthcare exchanges, 6 in 10 Americans (60%) said they feel no direct personal impact of the law, according to a survey...
Four years after the Patient Protection and Affordable Care Act (ACA) was passed and just months into the first year of healthcare exchanges, 6 in 10 Americans (60%) said they feel no direct personal impact of the law, according to a survey...
Four years after the Patient...
07/22/2014
First Report Managed Care
07/21/2014

Tim Casey

Tim Casey
Obese patients with type 2 diabetes are commonly prescribed medications and are further encouraged to exercise and improve their diets. In recent years, however, Roux-en-Y gastric bypass surgery, laparoscopic adjustable gastric banding...
Obese patients with type 2 diabetes are commonly prescribed medications and are further encouraged to exercise and improve their diets. In recent years, however, Roux-en-Y gastric bypass surgery, laparoscopic adjustable gastric banding...
Obese patients with type 2...
07/21/2014
First Report Managed Care

Advertisement

Advertisement

Advertisement